Trial intelligence / Profile preview

Factors affecting tyrosine kinase inhibitor response in chronic myeloid leukemia

TCTR20180703001Active, not recruiting

Sponsor
N/A
Start
Jul 2018
Countries
1
01

Overview

Trial in chronic myelogenous leukemia (CML), sponsored by N/A. Started Jul 2018; status: active, not recruiting.

02

Conditions

chronic myelogenous leukemia (CML)

Beyond the preview

Go deeper on TCTR20180703001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180703001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call